The Nisei Pharmacy A loss of R$2.95 million was incurred in the third quarter, representing a 78.4% reduction in losses on an annual basis. The company achieved revenue of R$850 million between July and September, an increase of 11.2% compared to the same period in 2024.
Third-quarter earnings before interest, taxes, depreciation and amortization (EBITDA) were R$92.9 million, an increase of 55.2% over the year. After adjustment, this indicator amounted to R$67 million, representing a growth of 65.5%.
“We ended the third quarter with solid results and consistent progress on our integration and business enhancement trajectory,” Pharmacias Nissei said in a statement.
The company highlighted that it ended the third quarter with 474 stores in 131 municipalities, compared to 432 stores in the same period in 2024. Approximately 30.5% of pharmacies are in the mature stage.
The company maintained its market leadership parana state They account for 15.2% of the state’s pharmacies. in Sao Paulo and Santa Catarina Nissay focused on expansion, reaching market shares of 4.11% and 4.16%, respectively.
The pharmacy chain’s costs and expenses decreased over the year, increasing its profit margins. Adjusted Ebitda margin increased from 5.03% to 7.4% in 12 months. This also reflects disciplined working capital management.
Nissay’s financial results for the third quarter were negative by R$72 million, affected by the high interest rate environment during the period, which put pressure on key funding lines and financial instruments.
The company’s net debt was 688.9 million reais at the end of September (compared to 521.7 million reais in the same period last year), but leverage decreased from 3.56x to 2.73x over the same period due to improved operating results.
About The Author
